No Data
Zhijiang Biology (688317.SH) plans to distribute 0.11 yuan per share and pay dividends on October 18th.
Zhi Jiang Biology (688317.SH) announced that the company's interim equity distribution for the first half of 2024 is proposed to be: cash dividend per share...
Zhijiang Biotechnology (688317.SH): The relevant biotechnology bills in the USA have not involved the company.
Zhejiang Biotechnology (688317.SH) stated on the interactive platform on September 18th that the relevant biotechnology legislation in the United States has not involved our company and has no direct impact. The company's main business is running normally and steadily. The company will closely monitor this matter.
Zhijiang Biology (688317.SH): has obtained the monkeypox product EU CE and UK MHRA certification.
On September 2, GeLongHui reported that ZhiJiang Biology (688317.SH) stated on the interactive platform that the company has obtained EU CE and United Kingdom MHRA certification for smallpox products, allowing sales in EU countries, the United Kingdom, and countries with relevant certifications. The company will continue to closely monitor the development of smallpox-related epidemics in overseas markets.
Zhijiang Biotech: 2024 Semi-Annual Report
Zhijiang Biotech: 2024 Semi-Annual Report Summary
Zhijiang Biology (688317.SH) released its semi-annual performance report, with a net income of 26.005 million yuan, a year-on-year decrease of 17.76%.
Zhi Jiang Biotech (688317.SH) has released its semi-annual report for 2024, reporting revenue of 9...
Some Shanghai ZJ Bio-Tech Co., Ltd. (SHSE:688317) Shareholders Look For Exit As Shares Take 27% PoundingNo Data
No Data
